nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—larynx—thyroid cancer	0.0851	0.337	CbGeAlD
Nedocromil—FPR1—head—thyroid cancer	0.0263	0.104	CbGeAlD
Nedocromil—PTGDR—head—thyroid cancer	0.0248	0.0981	CbGeAlD
Nedocromil—HSP90AA1—neck—thyroid cancer	0.0226	0.0892	CbGeAlD
Nedocromil—HSP90AA1—saliva-secreting gland—thyroid cancer	0.0176	0.0696	CbGeAlD
Nedocromil—PTGDR—lymph node—thyroid cancer	0.0174	0.0687	CbGeAlD
Nedocromil—HSP90AA1—trachea—thyroid cancer	0.0136	0.0537	CbGeAlD
Nedocromil—CYSLTR1—head—thyroid cancer	0.011	0.0434	CbGeAlD
Nedocromil—HSP90AA1—thyroid gland—thyroid cancer	0.0107	0.0425	CbGeAlD
Nedocromil—HSP90AA1—head—thyroid cancer	0.00952	0.0377	CbGeAlD
Nedocromil—CYSLTR1—lymph node—thyroid cancer	0.00769	0.0304	CbGeAlD
Nedocromil—HSP90AA1—lymph node—thyroid cancer	0.00667	0.0264	CbGeAlD
Nedocromil—Dysphonia—Sorafenib—thyroid cancer	0.00658	0.0295	CcSEcCtD
Nedocromil—Gastroenteritis—Vandetanib—thyroid cancer	0.00657	0.0295	CcSEcCtD
Nedocromil—Influenza—Vandetanib—thyroid cancer	0.00504	0.0226	CcSEcCtD
Nedocromil—Bronchitis—Vandetanib—thyroid cancer	0.00484	0.0217	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00468	0.021	CcSEcCtD
Nedocromil—Pneumonia—Vandetanib—thyroid cancer	0.00452	0.0202	CcSEcCtD
Nedocromil—Eczema—Sorafenib—thyroid cancer	0.00437	0.0196	CcSEcCtD
Nedocromil—Conjunctivitis—Vandetanib—thyroid cancer	0.00436	0.0196	CcSEcCtD
Nedocromil—Sinusitis—Vandetanib—thyroid cancer	0.00421	0.0189	CcSEcCtD
Nedocromil—Visual impairment—Vandetanib—thyroid cancer	0.00388	0.0174	CcSEcCtD
Nedocromil—Dysgeusia—Vandetanib—thyroid cancer	0.00344	0.0154	CcSEcCtD
Nedocromil—Tremor—Vandetanib—thyroid cancer	0.00329	0.0147	CcSEcCtD
Nedocromil—Cough—Vandetanib—thyroid cancer	0.00306	0.0137	CcSEcCtD
Nedocromil—Pneumonia—Sorafenib—thyroid cancer	0.00305	0.0137	CcSEcCtD
Nedocromil—Chest pain—Vandetanib—thyroid cancer	0.00299	0.0134	CcSEcCtD
Nedocromil—Dry mouth—Vandetanib—thyroid cancer	0.00292	0.0131	CcSEcCtD
Nedocromil—Rash erythematous—Epirubicin—thyroid cancer	0.00261	0.0117	CcSEcCtD
Nedocromil—Otitis media—Epirubicin—thyroid cancer	0.00257	0.0115	CcSEcCtD
Nedocromil—Dyspnoea—Vandetanib—thyroid cancer	0.00255	0.0114	CcSEcCtD
Nedocromil—Feeling hot—Epirubicin—thyroid cancer	0.00255	0.0114	CcSEcCtD
Nedocromil—Dyspepsia—Vandetanib—thyroid cancer	0.00252	0.0113	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00247	0.0111	CcSEcCtD
Nedocromil—Stinging—Epirubicin—thyroid cancer	0.00247	0.0111	CcSEcCtD
Nedocromil—Fatigue—Vandetanib—thyroid cancer	0.00247	0.0111	CcSEcCtD
Nedocromil—Pain—Vandetanib—thyroid cancer	0.00245	0.011	CcSEcCtD
Nedocromil—Dysphonia—Epirubicin—thyroid cancer	0.00243	0.0109	CcSEcCtD
Nedocromil—Rash erythematous—Doxorubicin—thyroid cancer	0.00242	0.0108	CcSEcCtD
Nedocromil—Otitis media—Doxorubicin—thyroid cancer	0.00238	0.0107	CcSEcCtD
Nedocromil—Feeling hot—Doxorubicin—thyroid cancer	0.00236	0.0106	CcSEcCtD
Nedocromil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00234	0.0105	CcSEcCtD
Nedocromil—Dysgeusia—Sorafenib—thyroid cancer	0.00232	0.0104	CcSEcCtD
Nedocromil—Stinging—Doxorubicin—thyroid cancer	0.00229	0.0102	CcSEcCtD
Nedocromil—Abdominal pain—Vandetanib—thyroid cancer	0.00226	0.0102	CcSEcCtD
Nedocromil—Body temperature increased—Vandetanib—thyroid cancer	0.00226	0.0102	CcSEcCtD
Nedocromil—Dysphonia—Doxorubicin—thyroid cancer	0.00225	0.0101	CcSEcCtD
Nedocromil—Viral infection—Epirubicin—thyroid cancer	0.00222	0.00993	CcSEcCtD
Nedocromil—Cough increased—Epirubicin—thyroid cancer	0.00219	0.0098	CcSEcCtD
Nedocromil—Leukopenia—Sorafenib—thyroid cancer	0.00212	0.0095	CcSEcCtD
Nedocromil—Cough—Sorafenib—thyroid cancer	0.00207	0.00926	CcSEcCtD
Nedocromil—Asthenia—Vandetanib—thyroid cancer	0.00205	0.00921	CcSEcCtD
Nedocromil—Viral infection—Doxorubicin—thyroid cancer	0.00205	0.00919	CcSEcCtD
Nedocromil—Cough increased—Doxorubicin—thyroid cancer	0.00202	0.00907	CcSEcCtD
Nedocromil—Dry mouth—Sorafenib—thyroid cancer	0.00197	0.00884	CcSEcCtD
Nedocromil—Diarrhoea—Vandetanib—thyroid cancer	0.00196	0.00879	CcSEcCtD
Nedocromil—Anaphylactic shock—Sorafenib—thyroid cancer	0.00193	0.00866	CcSEcCtD
Nedocromil—Dizziness—Vandetanib—thyroid cancer	0.00189	0.00849	CcSEcCtD
Nedocromil—Vomiting—Vandetanib—thyroid cancer	0.00182	0.00816	CcSEcCtD
Nedocromil—Rash—Vandetanib—thyroid cancer	0.00181	0.0081	CcSEcCtD
Nedocromil—Dermatitis—Vandetanib—thyroid cancer	0.0018	0.00809	CcSEcCtD
Nedocromil—Headache—Vandetanib—thyroid cancer	0.00179	0.00804	CcSEcCtD
Nedocromil—Dyspnoea—Sorafenib—thyroid cancer	0.00172	0.00772	CcSEcCtD
Nedocromil—Nausea—Vandetanib—thyroid cancer	0.0017	0.00763	CcSEcCtD
Nedocromil—Dyspepsia—Sorafenib—thyroid cancer	0.0017	0.00762	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00167	0.00748	CcSEcCtD
Nedocromil—Fatigue—Sorafenib—thyroid cancer	0.00167	0.00747	CcSEcCtD
Nedocromil—Pain—Sorafenib—thyroid cancer	0.00165	0.00741	CcSEcCtD
Nedocromil—Eczema—Epirubicin—thyroid cancer	0.00162	0.00725	CcSEcCtD
Nedocromil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00158	0.00708	CcSEcCtD
Nedocromil—Urticaria—Sorafenib—thyroid cancer	0.00153	0.00688	CcSEcCtD
Nedocromil—Abdominal pain—Sorafenib—thyroid cancer	0.00153	0.00685	CcSEcCtD
Nedocromil—Body temperature increased—Sorafenib—thyroid cancer	0.00153	0.00685	CcSEcCtD
Nedocromil—Eczema—Doxorubicin—thyroid cancer	0.0015	0.00671	CcSEcCtD
Nedocromil—Hypersensitivity—Sorafenib—thyroid cancer	0.00142	0.00638	CcSEcCtD
Nedocromil—Asthenia—Sorafenib—thyroid cancer	0.00139	0.00621	CcSEcCtD
Nedocromil—Diarrhoea—Sorafenib—thyroid cancer	0.00132	0.00593	CcSEcCtD
Nedocromil—Dizziness—Sorafenib—thyroid cancer	0.00128	0.00573	CcSEcCtD
Nedocromil—Influenza—Epirubicin—thyroid cancer	0.00126	0.00563	CcSEcCtD
Nedocromil—Eosinophilia—Epirubicin—thyroid cancer	0.00124	0.00557	CcSEcCtD
Nedocromil—Vomiting—Sorafenib—thyroid cancer	0.00123	0.00551	CcSEcCtD
Nedocromil—Rash—Sorafenib—thyroid cancer	0.00122	0.00546	CcSEcCtD
Nedocromil—Dermatitis—Sorafenib—thyroid cancer	0.00122	0.00546	CcSEcCtD
Nedocromil—Headache—Sorafenib—thyroid cancer	0.00121	0.00543	CcSEcCtD
Nedocromil—Bronchitis—Epirubicin—thyroid cancer	0.00121	0.00541	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00117	0.00523	CcSEcCtD
Nedocromil—Influenza—Doxorubicin—thyroid cancer	0.00116	0.00521	CcSEcCtD
Nedocromil—Eosinophilia—Doxorubicin—thyroid cancer	0.00115	0.00516	CcSEcCtD
Nedocromil—Nausea—Sorafenib—thyroid cancer	0.00115	0.00514	CcSEcCtD
Nedocromil—Pneumonia—Epirubicin—thyroid cancer	0.00113	0.00505	CcSEcCtD
Nedocromil—Bronchitis—Doxorubicin—thyroid cancer	0.00112	0.00501	CcSEcCtD
Nedocromil—Conjunctivitis—Epirubicin—thyroid cancer	0.00109	0.00488	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00108	0.00484	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—TSHR—thyroid cancer	0.00106	0.00202	CbGpPWpGaD
Nedocromil—Sinusitis—Epirubicin—thyroid cancer	0.00105	0.00471	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—SST—thyroid cancer	0.00105	0.002	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CALCA—thyroid cancer	0.00104	0.00199	CbGpPWpGaD
Nedocromil—Pneumonia—Doxorubicin—thyroid cancer	0.00104	0.00467	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00104	0.00199	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TRIM24—thyroid cancer	0.00102	0.00195	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CALCA—thyroid cancer	0.00101	0.00192	CbGpPWpGaD
Nedocromil—Rhinitis—Epirubicin—thyroid cancer	0.00101	0.00452	CcSEcCtD
Nedocromil—Conjunctivitis—Doxorubicin—thyroid cancer	0.00101	0.00451	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—MINPP1—thyroid cancer	0.001	0.00192	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrin-linked kinase signaling—AKT1—thyroid cancer	0.000998	0.0019	CbGpPWpGaD
Nedocromil—Pharyngitis—Epirubicin—thyroid cancer	0.000997	0.00447	CcSEcCtD
Nedocromil—Sinusitis—Doxorubicin—thyroid cancer	0.000972	0.00436	CcSEcCtD
Nedocromil—Visual impairment—Epirubicin—thyroid cancer	0.000968	0.00434	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000968	0.00185	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CHST14—thyroid cancer	0.000959	0.00183	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CDK1—thyroid cancer	0.000946	0.0018	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CALCB—thyroid cancer	0.000935	0.00178	CbGpPWpGaD
Nedocromil—Rhinitis—Doxorubicin—thyroid cancer	0.000932	0.00418	CcSEcCtD
Nedocromil—Pharyngitis—Doxorubicin—thyroid cancer	0.000923	0.00414	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CDK1—thyroid cancer	0.000913	0.00174	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TRIM33—thyroid cancer	0.000909	0.00173	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—SST—thyroid cancer	0.000906	0.00173	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PTCH1—thyroid cancer	0.000899	0.00172	CbGpPWpGaD
Nedocromil—Visual impairment—Doxorubicin—thyroid cancer	0.000896	0.00402	CcSEcCtD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000888	0.00169	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—CDK1—thyroid cancer	0.000888	0.00169	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TRIM33—thyroid cancer	0.000887	0.00169	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CALCA—thyroid cancer	0.000872	0.00166	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—NRAS—thyroid cancer	0.000872	0.00166	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TPR—thyroid cancer	0.000865	0.00165	CbGpPWpGaD
Nedocromil—Dysgeusia—Epirubicin—thyroid cancer	0.000857	0.00384	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—NDUFA13—thyroid cancer	0.000854	0.00163	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TCF7L1—thyroid cancer	0.000854	0.00163	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RAP1GAP—thyroid cancer	0.000837	0.0016	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TSHR—thyroid cancer	0.000824	0.00157	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—SST—thyroid cancer	0.000823	0.00157	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—LGALS3—thyroid cancer	0.000819	0.00156	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PRKAR1A—thyroid cancer	0.000812	0.00155	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000811	0.00155	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TSHR—thyroid cancer	0.000807	0.00154	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CHST14—thyroid cancer	0.000803	0.00153	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TSHR—thyroid cancer	0.000796	0.00152	CbGpPWpGaD
Nedocromil—Dysgeusia—Doxorubicin—thyroid cancer	0.000793	0.00355	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CALCA—thyroid cancer	0.000792	0.00151	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PRKAR1A—thyroid cancer	0.000783	0.00149	CbGpPWpGaD
Nedocromil—Leukopenia—Epirubicin—thyroid cancer	0.000783	0.00351	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—MEN1—thyroid cancer	0.000775	0.00148	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—thyroid cancer	0.000772	0.00147	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000765	0.00146	CbGpPWpGaD
Nedocromil—Cough—Epirubicin—thyroid cancer	0.000763	0.00342	CcSEcCtD
Nedocromil—HSP90AA1—Integrins in angiogenesis—AKT1—thyroid cancer	0.000762	0.00145	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000753	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—KRAS—thyroid cancer	0.00075	0.00143	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MEN1—thyroid cancer	0.000749	0.00143	CbGpPWpGaD
Nedocromil—Chest pain—Epirubicin—thyroid cancer	0.000745	0.00334	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—TSHR—thyroid cancer	0.000733	0.0014	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000731	0.00139	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—NRAS—thyroid cancer	0.000729	0.00139	CbGpPWpGaD
Nedocromil—Dry mouth—Epirubicin—thyroid cancer	0.000728	0.00327	CcSEcCtD
Nedocromil—Leukopenia—Doxorubicin—thyroid cancer	0.000725	0.00325	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000721	0.00138	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—HIF1A—thyroid cancer	0.000721	0.00137	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thyroid cancer	0.000717	0.00137	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—AKT1—thyroid cancer	0.000717	0.00137	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CDK1—thyroid cancer	0.000717	0.00137	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Epirubicin—thyroid cancer	0.000714	0.0032	CcSEcCtD
Nedocromil—Cough—Doxorubicin—thyroid cancer	0.000706	0.00317	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—PTCH1—thyroid cancer	0.000701	0.00134	CbGpPWpGaD
Nedocromil—Chest pain—Doxorubicin—thyroid cancer	0.000689	0.00309	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—PTCH1—thyroid cancer	0.000677	0.00129	CbGpPWpGaD
Nedocromil—Dry mouth—Doxorubicin—thyroid cancer	0.000674	0.00302	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—CALCB—thyroid cancer	0.000671	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—KRAS—thyroid cancer	0.000665	0.00127	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000661	0.00296	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000656	0.00125	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.00065	0.00124	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HPGD—thyroid cancer	0.000647	0.00123	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SST—thyroid cancer	0.000641	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.000638	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TRIM33—thyroid cancer	0.000637	0.00121	CbGpPWpGaD
Nedocromil—Dyspnoea—Epirubicin—thyroid cancer	0.000637	0.00285	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—CDK1—thyroid cancer	0.000633	0.00121	CbGpPWpGaD
Nedocromil—Dyspepsia—Epirubicin—thyroid cancer	0.000628	0.00282	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—SST—thyroid cancer	0.000628	0.0012	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—KRAS—thyroid cancer	0.000628	0.0012	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—thyroid cancer	0.000627	0.0012	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TSHR—thyroid cancer	0.000625	0.00119	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PTCH1—thyroid cancer	0.000623	0.00119	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SST—thyroid cancer	0.000619	0.00118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—PTEN—thyroid cancer	0.000618	0.00118	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.000617	0.00118	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CALCA—thyroid cancer	0.000617	0.00118	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000616	0.00276	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000616	0.00117	CbGpPWpGaD
Nedocromil—Fatigue—Epirubicin—thyroid cancer	0.000616	0.00276	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000615	0.00117	CbGpPWpGaD
Nedocromil—Pain—Epirubicin—thyroid cancer	0.000611	0.00274	CcSEcCtD
Nedocromil—HSP90AA1—Disease—TCF7L1—thyroid cancer	0.000607	0.00116	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CALCA—thyroid cancer	0.000604	0.00115	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CALCA—thyroid cancer	0.000596	0.00114	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000592	0.00113	CbGpPWpGaD
Nedocromil—Dyspnoea—Doxorubicin—thyroid cancer	0.000589	0.00264	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—RXRA—thyroid cancer	0.000588	0.00112	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MEN1—thyroid cancer	0.000587	0.00112	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDK1—thyroid cancer	0.000586	0.00112	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000584	0.00262	CcSEcCtD
Nedocromil—Dyspepsia—Doxorubicin—thyroid cancer	0.000582	0.00261	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00057	0.00256	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—SST—thyroid cancer	0.00057	0.00109	CbGpPWpGaD
Nedocromil—Fatigue—Doxorubicin—thyroid cancer	0.00057	0.00255	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PTEN—thyroid cancer	0.000569	0.00108	CbGpPWpGaD
Nedocromil—Urticaria—Epirubicin—thyroid cancer	0.000567	0.00254	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	0.000565	0.00108	CbGpPWpGaD
Nedocromil—Pain—Doxorubicin—thyroid cancer	0.000565	0.00253	CcSEcCtD
Nedocromil—Body temperature increased—Epirubicin—thyroid cancer	0.000564	0.00253	CcSEcCtD
Nedocromil—Abdominal pain—Epirubicin—thyroid cancer	0.000564	0.00253	CcSEcCtD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000563	0.00107	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000563	0.00107	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDK1—thyroid cancer	0.000559	0.00107	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDK1—thyroid cancer	0.000559	0.00107	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—NRAS—thyroid cancer	0.000552	0.00105	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CALCA—thyroid cancer	0.000549	0.00105	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00054	0.00242	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CDK1—thyroid cancer	0.00054	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IFNA2—thyroid cancer	0.000538	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—thyroid cancer	0.000533	0.00102	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTCH1—thyroid cancer	0.000531	0.00101	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.00053	0.00101	CbGpPWpGaD
Nedocromil—Hypersensitivity—Epirubicin—thyroid cancer	0.000526	0.00236	CcSEcCtD
Nedocromil—Urticaria—Doxorubicin—thyroid cancer	0.000525	0.00235	CcSEcCtD
Nedocromil—Abdominal pain—Doxorubicin—thyroid cancer	0.000522	0.00234	CcSEcCtD
Nedocromil—Body temperature increased—Doxorubicin—thyroid cancer	0.000522	0.00234	CcSEcCtD
Nedocromil—Asthenia—Epirubicin—thyroid cancer	0.000512	0.0023	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—NRAS—thyroid cancer	0.000507	0.000968	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	0.000499	0.000952	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CDK1—thyroid cancer	0.000497	0.000948	CbGpPWpGaD
Nedocromil—Diarrhoea—Epirubicin—thyroid cancer	0.000489	0.00219	CcSEcCtD
Nedocromil—Hypersensitivity—Doxorubicin—thyroid cancer	0.000487	0.00218	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—SST—thyroid cancer	0.000486	0.000927	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TPR—thyroid cancer	0.000481	0.000917	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—LGALS3—thyroid cancer	0.000477	0.00091	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KRAS—thyroid cancer	0.000475	0.000906	CbGpPWpGaD
Nedocromil—Asthenia—Doxorubicin—thyroid cancer	0.000474	0.00213	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—PRKAR1A—thyroid cancer	0.000473	0.000902	CbGpPWpGaD
Nedocromil—Dizziness—Epirubicin—thyroid cancer	0.000472	0.00212	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—AKT1—thyroid cancer	0.000471	0.000899	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CALCA—thyroid cancer	0.000468	0.000892	CbGpPWpGaD
Nedocromil—Vomiting—Epirubicin—thyroid cancer	0.000454	0.00204	CcSEcCtD
Nedocromil—Diarrhoea—Doxorubicin—thyroid cancer	0.000452	0.00203	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000451	0.000859	CbGpPWpGaD
Nedocromil—Rash—Epirubicin—thyroid cancer	0.00045	0.00202	CcSEcCtD
Nedocromil—Dermatitis—Epirubicin—thyroid cancer	0.00045	0.00202	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—NRG1—thyroid cancer	0.000449	0.000857	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NRG1—thyroid cancer	0.000448	0.000855	CbGpPWpGaD
Nedocromil—Headache—Epirubicin—thyroid cancer	0.000447	0.00201	CcSEcCtD
Nedocromil—HSP90AA1—Disease—TPR—thyroid cancer	0.000444	0.000847	CbGpPWpGaD
Nedocromil—Dizziness—Doxorubicin—thyroid cancer	0.000437	0.00196	CcSEcCtD
Nedocromil—HSP90AA1—Disease—PRKAR1A—thyroid cancer	0.000437	0.000833	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.000437	0.000833	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TSHR—thyroid cancer	0.000433	0.000826	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NRG1—thyroid cancer	0.000433	0.000826	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000426	0.000813	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TCF7L1—thyroid cancer	0.000425	0.00081	CbGpPWpGaD
Nedocromil—Nausea—Epirubicin—thyroid cancer	0.000424	0.0019	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CDK1—thyroid cancer	0.000423	0.000808	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TERT—thyroid cancer	0.000423	0.000806	CbGpPWpGaD
Nedocromil—Vomiting—Doxorubicin—thyroid cancer	0.00042	0.00188	CcSEcCtD
Nedocromil—HSP90AA1—Disease—MEN1—thyroid cancer	0.000417	0.000796	CbGpPWpGaD
Nedocromil—Rash—Doxorubicin—thyroid cancer	0.000417	0.00187	CcSEcCtD
Nedocromil—Dermatitis—Doxorubicin—thyroid cancer	0.000416	0.00187	CcSEcCtD
Nedocromil—Headache—Doxorubicin—thyroid cancer	0.000414	0.00186	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—MEN1—thyroid cancer	0.000407	0.000777	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—thyroid cancer	0.000404	0.00077	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TERT—thyroid cancer	0.000403	0.000768	CbGpPWpGaD
Nedocromil—Nausea—Doxorubicin—thyroid cancer	0.000392	0.00176	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—TERT—thyroid cancer	0.000389	0.000742	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HIF1A—thyroid cancer	0.000385	0.000735	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HIF1A—thyroid cancer	0.000372	0.000709	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TPR—thyroid cancer	0.000372	0.000709	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—PPARG—thyroid cancer	0.000371	0.000708	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.000371	0.000708	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTCH1—thyroid cancer	0.000368	0.000703	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PRKAR1A—thyroid cancer	0.000366	0.000698	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—thyroid cancer	0.000356	0.00068	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NRG1—thyroid cancer	0.00034	0.000648	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—NRAS—thyroid cancer	0.000339	0.000647	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SST—thyroid cancer	0.000337	0.000643	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CALCA—thyroid cancer	0.000332	0.000634	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000328	0.000625	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—NRAS—thyroid cancer	0.000328	0.000625	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDK1—thyroid cancer	0.000326	0.000622	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CALCA—thyroid cancer	0.000324	0.000618	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—BRAF—thyroid cancer	0.000319	0.000608	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—NRAS—thyroid cancer	0.000318	0.000607	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNA2—thyroid cancer	0.000313	0.000598	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TSHR—thyroid cancer	0.000311	0.000593	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—BRAF—thyroid cancer	0.000308	0.000587	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000306	0.000583	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TERT—thyroid cancer	0.000305	0.000582	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDK1—thyroid cancer	0.000301	0.000574	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDK1—thyroid cancer	0.000293	0.00056	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MEN1—thyroid cancer	0.000292	0.000558	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—KRAS—thyroid cancer	0.000292	0.000557	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HIF1A—thyroid cancer	0.000292	0.000557	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—thyroid cancer	0.000287	0.000547	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—KRAS—thyroid cancer	0.000282	0.000538	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC5A5—thyroid cancer	0.000278	0.000531	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—KRAS—thyroid cancer	0.000274	0.000523	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.000273	0.000521	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTCH1—thyroid cancer	0.000264	0.000504	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NRG1—thyroid cancer	0.000262	0.000499	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—NRAS—thyroid cancer	0.000257	0.00049	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—thyroid cancer	0.000248	0.000473	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—thyroid cancer	0.000244	0.000466	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SST—thyroid cancer	0.000242	0.000461	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—BRAF—thyroid cancer	0.000242	0.000461	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NRG1—thyroid cancer	0.000241	0.000461	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—thyroid cancer	0.000241	0.00046	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—thyroid cancer	0.00024	0.000457	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NRG1—thyroid cancer	0.000236	0.000449	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—RXRA—thyroid cancer	0.000234	0.000446	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—thyroid cancer	0.000233	0.000445	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—thyroid cancer	0.000233	0.000444	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CALCA—thyroid cancer	0.000233	0.000444	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—thyroid cancer	0.000233	0.000444	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NRAS—thyroid cancer	0.000227	0.000433	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PTEN—thyroid cancer	0.000225	0.000429	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—thyroid cancer	0.000225	0.000429	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PTEN—thyroid cancer	0.000225	0.000428	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—KRAS—thyroid cancer	0.000221	0.000422	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—thyroid cancer	0.000219	0.000418	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PTEN—thyroid cancer	0.000217	0.000414	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TERT—thyroid cancer	0.000217	0.000414	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—thyroid cancer	0.000212	0.000404	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TERT—thyroid cancer	0.000212	0.000403	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDK1—thyroid cancer	0.000211	0.000402	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HIF1A—thyroid cancer	0.000207	0.000396	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HIF1A—thyroid cancer	0.000202	0.000386	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NRAS—thyroid cancer	0.000201	0.000383	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NRAS—thyroid cancer	0.0002	0.000382	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KRAS—thyroid cancer	0.000196	0.000373	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NRAS—thyroid cancer	0.000194	0.000369	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—thyroid cancer	0.000188	0.000359	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—thyroid cancer	0.000183	0.000349	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—NRAS—thyroid cancer	0.000178	0.00034	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—thyroid cancer	0.000176	0.000336	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KRAS—thyroid cancer	0.000173	0.000329	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KRAS—thyroid cancer	0.000172	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—BRAF—thyroid cancer	0.000172	0.000328	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTEN—thyroid cancer	0.00017	0.000325	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NRG1—thyroid cancer	0.000169	0.000323	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—BRAF—thyroid cancer	0.000168	0.00032	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KRAS—thyroid cancer	0.000167	0.000318	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—thyroid cancer	0.000166	0.000317	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—thyroid cancer	0.000166	0.000317	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—thyroid cancer	0.000161	0.000307	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KRAS—thyroid cancer	0.000153	0.000293	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—thyroid cancer	0.000153	0.000292	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NRAS—thyroid cancer	0.000152	0.00029	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TERT—thyroid cancer	0.000152	0.00029	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—thyroid cancer	0.000148	0.000282	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPARG—thyroid cancer	0.000148	0.000282	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—thyroid cancer	0.000147	0.00028	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—thyroid cancer	0.000147	0.00028	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—thyroid cancer	0.000147	0.00028	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HIF1A—thyroid cancer	0.000145	0.000277	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—thyroid cancer	0.000142	0.00027	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—thyroid cancer	0.000139	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTEN—thyroid cancer	0.000131	0.00025	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KRAS—thyroid cancer	0.000131	0.000249	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—thyroid cancer	0.00013	0.000249	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—thyroid cancer	0.00013	0.000247	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—thyroid cancer	0.000129	0.000247	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—thyroid cancer	0.000127	0.000242	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—thyroid cancer	0.000125	0.000238	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—thyroid cancer	0.000122	0.000233	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTEN—thyroid cancer	0.000121	0.000231	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—BRAF—thyroid cancer	0.00012	0.000229	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTEN—thyroid cancer	0.000118	0.000225	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NRAS—thyroid cancer	0.000117	0.000223	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—thyroid cancer	0.000116	0.000222	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—thyroid cancer	0.000116	0.000222	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—thyroid cancer	0.000115	0.00022	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—thyroid cancer	0.000111	0.000212	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NRAS—thyroid cancer	0.000108	0.000206	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NRAS—thyroid cancer	0.000105	0.000201	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTEN—thyroid cancer	0.000101	0.000193	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KRAS—thyroid cancer	0.000101	0.000192	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—thyroid cancer	9.81e-05	0.000187	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KRAS—thyroid cancer	9.29e-05	0.000177	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KRAS—thyroid cancer	9.06e-05	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—thyroid cancer	8.77e-05	0.000167	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—thyroid cancer	8.55e-05	0.000163	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTEN—thyroid cancer	8.47e-05	0.000162	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—thyroid cancer	8.05e-05	0.000154	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—thyroid cancer	7.89e-05	0.000151	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—thyroid cancer	7.7e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NRAS—thyroid cancer	7.56e-05	0.000144	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—thyroid cancer	7.55e-05	0.000144	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—thyroid cancer	6.97e-05	0.000133	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—thyroid cancer	6.8e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KRAS—thyroid cancer	6.5e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—thyroid cancer	5.84e-05	0.000111	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—thyroid cancer	5.78e-05	0.00011	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—thyroid cancer	5.53e-05	0.000105	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—thyroid cancer	4.88e-05	9.31e-05	CbGpPWpGaD
